Clinical Trial Update: Paclitaxel-bevacizumab in Advanced Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for paclitaxel-bevacizumab in non-squamous non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Paclitaxel-bevacizumab

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED